Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2011; 17(28): 3347-3352
Published online Jul 28, 2011. doi: 10.3748/wjg.v17.i28.3347
Table 1 Univariate analysis for baseline characteristics
VariableNon-rebleeding (n = 316)Rebleeding (n = 26)P-valueOR95% CI
Male/female227/8915/110.13
Age (yr)52.3 ± 11.057.5 ± 8.30.02
Etiology of cirrhosis
Virus237210.60
Alcohol311
Others484
Comorbidities
Diabetes3550.21
Liver cancer1920.67
History of surgery
Splenectomy or devascularization10016< 0.013.081.38-6.88
Liver cancer surgery801
Liver transplantation301
Child-Pugh score
A1251< 0.01
B1736
C1819
Encephalopathy810< 0.0124.068.36-69.23
Blood loss before EVL (mL)736 ± 4181854 ± 657< 0.01
Ascites
None/mild2856< 0.0126.1810.25-66.82
Moderate/excessive3120
Portal vein diameter (mm)12.9 ± 2.115.9 ± 2.2< 0.01
Portal vein diameter ≥ 14 mm11324< 0.0121.565.00-92.89
Portal vein thrombosis3713< 0.017.543.25-17.50
Hemoglobin (g/L)97.0 ± 20.871.8 ± 13.2< 0.01
Hemoglobin < 90 g/L11224< 0.0121.865.07-94.19
Platelets (109/L)121 ± 7796 ± 990.118
Albumin (g/L)35.2 ± 5.629.2 ± 4.2< 0.01
Albumin < 28 g/L328< 0.013.941.59-9.79
ALT (U/L)32.4 ± 22.236.0 ± 18.40.42
AKP (U/L)108.3 ± 200.1142.8 ± 96.50.39
Bilirubin (μmol/L)21.4 ± 13.427.7 ± 14.90.02
Bilirubin > 34 μmol/L349< 0.014.391.82-10.62
PT (s)15.7 ± 2.420.1 ± 3.5< 0.01
PT > 18 s4320< 0.0119.077.21-45.30